Enzyme replacement treatment in type 1 and type 3 Gaucher's disease
- 1 December 1994
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 344 (8938) , 1679-1682
- https://doi.org/10.1016/s0140-6736(94)90462-6
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The Role of Neurogenetics in Gaucher DiseaseArchives of Neurology, 1993
- Gaucher disease: new molecular approaches to diagnosis and treatmentScience, 1992
- Acid β-Glucosidase: Enzymology and Molecular Biology of Gaucher DiseasCritical Reviews in Biochemistry and Molecular Biology, 1990
- PREDICTION OF SEVERITY OF GAUCHER'S DISEASE BY IDENTIFICATION OF MUTATIONS AT DNA LEVELThe Lancet, 1989
- The human glucocerebrosidase gene and pseudogene: Structure and evolutionGenomics, 1989
- Structural Analysis of the Human Glucocerebrosidase GenesDNA, 1988
- A Mutation in the Human Glucocerebrosidase Gene in Neuronopathic Gaucher's DiseaseNew England Journal of Medicine, 1987
- The Varied Clinical and Laboratory Manifestations of Type II Gaucher's DiseaseActa Paediatrica, 1987
- Type 2 and type 3 Gaucher disease: A morphological and biochemical studyAnnals of Neurology, 1986
- Replacement Therapy for Inherited Enzyme DeficiencyNew England Journal of Medicine, 1974